From the banks of the Huangpu River to the foot of the Alps, from academic halls to live surgery rooms, in 2025 Ligatech's footsteps crossed mountains and seas, reaching where the pulse of global medicine beats. Weused81 high-quality academic conferences to weave a network connecting innovation, clinical practice and the market，, writing a vivid footnote for our annual report.
81 is not just a number; it is proof of our deep involvement in the industrial core and academic frontier:
This year, our presence was active in domestic academic highlands such as Shanghai, Beijing and Hangzhou,and，we also appeared on international stages such as Germany, Peru and Thailand,，advancing our Global Presence.
This year, we deeply participated in the academic exchange events of major medical associations with the first domestic artificial ligament, walking alongside top experts; at the same time, we took the initiative to build platforms and successfully held13high-difficulty "live surgeries" and8practical classes, allowing innovative technology to be reviewed in real combat and enabling participants toread and understand the "manual" of clinical artificial ligament operation.
Every voice we raised was to get closer to clinical practice.
By 2025, Ligatech's artificial ligaments had entered nearly1000hospitals, covering many Class IIIA hospitals and primary-level hospitals across the country. Ligatech alwaystakes actual clinical outcomes as the core mission of its products. In the "Liren Arthroscopy" series of conferences, surgeons shared clinical operating key points with participants through live surgeries, promoting the standardized and systematic development of clinical practical techniques.The core mission of the product found its footing through clinical skills.
Adhering to the vision of "leader of domestic sports medicine", Ligatech keeps its head down to move forward while never forgetting to look up at the road.
In the 2024 national centralized procurement, Ligatech's artificial ligaments occupied a largemarket share, taking the lead in achievingthe "zero"breakthrough for domestic artificial ligaments.
On June 22, 2025, Ms. Huo Hongya, Textile Technology Director of Shanghai Ligatech Bioscience Co., Ltd., was invited to attend the 2025 China Biomedical Engineering Conference and Innovative Medical Summit, sharing industry insights and thoughts on "Thinking and Prospects Based on Artificial Ligament Raw Materials". Whether in academic exchange or industry-academia-research cooperation, Ligatechtakes artificial ligament products as a breakthrough point, aiming to jointly build a new ecosystem for the sports medicine industry。
In 2026, our conference journey sets sail again. We will not stop at "participation" but are committed to"construction".：
Refresh our city footprint:Reach more cities and continue to walk alongside the industry frontier.
Upgrade interaction platforms:Build a higher-frequency, more immersive "online + offline" surgery exchange and training system.
Deepen industry dialogue:Participate more deeply in industry standard discussions and deepen technical research in the sports medicine industry.
Related News
-
Product Innovation"Sports Medicine Research" Magazine Officially to Be Launched!
2026.04.13 -
![[Reprint] Sports Medicine Frontier:](/uploads/20260731/682192581f69e0f0699ea5918229b1a6.png)
Media Reports[Reprint] Sports Medicine Frontier: "Breaking New Ground, Leading the Future | The Cross-Regional Chinese Artificial Ligament and Patch Research Society Officially Established"!
2026.06.01 -
Academic ActivitiesRecap | Ligatech Academic Meetings, January 2026
2026.02.09
